Notice pursuant to Section 10 of the German Act on Advertising in the Healthcare Sector (HWG)

This content is intended exclusively for healthcare professionals.

In accordance with Section 10 of the German Act on Advertising in the Healthcare Sector (Heilmittelwerbegesetz - HWG), advertising for prescription-only medicines – including medical cannabis – may only be directed at individuals who prescribe, dispense, or administer these medicines.

The content published on this website consists exclusively of experience reports and professional assessments by experts. It does not constitute a promise of cure, a therapy recommendation, or an invitation to self-medication. The event serves the professional discourse on the establishment of medicinal cannabis in a professional medical context.

By confirming, you declare that you are a healthcare professional within the meaning of Section 10 HWG (e.g., physician, pharmacist, nursing professional, naturopath, therapist).

Access denied

This page is exclusively for healthcare professionals. You will be redirected in 6 seconds until redirect

Pain Medicine
Pharmacology

André Ihlenfeld

Anesthesiologist and pain physician, Medical Director

-

Copeia

Dr. André Ihlenfeld is a specialist in anesthesiology and a pain physician, as well as Medical Director at Copeia, where he is responsible for projects on patient-reported data collection under cannabis therapy (including the Physicians Experience Platform). He is co-author of publications on cannabis-based medicines.

Lernen Sie

André Ihlenfeld

persönlich kennen

Logo von Four 20 Pharma mit dem Text Circle of Experts vor einem stilisierten Cannabisblatt.

Specialist in anesthesiology and pain management with a focus on patient-based data collection in cannabis medicine.

Werdegang

Dr. André Ihlenfeld is a board-certified specialist in anesthesiology and a pain physician.

He studied human medicine at the Charité Berlin and completed his specialist training at several Berlin hospitals, including St. Hedwig Krankenhaus, St. Josefs Krankenhaus and DRK Kliniken Berlin, where from 2008 to 2018 he held various positions as resident, specialist and senior physician. He later served as senior physician at Asklepios (2018–2019) and as a freelance physician at Hays (2019–2020).

Since October 2020 he has been a Medical Editor at AMBOSS in Berlin and works as a Senior Physician in Anesthesiology & Intensive Care. He is Medical Director of Copeia GmbH, where he leads projects on the collection of patient-reported outcomes under cannabis therapy, including the Physicians Experience Platform (PEP).

As an expert, he takes part in 420Pharma's Circle of Experts and is co-author of publications on cannabis-based medicines.

Social Media, PubMed und Co.

Externe Profile

Website

https://www.copeia.de/

LinkedIn

https://www.linkedin.com/in/andr%C3%A9-ihlenfeld-76589773

PubMed

https://pubmed.ncbi.nlm.nih.gov/?term=Ihlenfeld+A

Beim nächsten Circle of Experts dabei sein.

Die Plätze vor Ort sind begrenzt. Bitte melden Sie sich verbindlich an — eine Bestätigung mit allen Details zum Programm erhalten Sie unmittelbar nach Ihrer Anmeldung.

00:00

/

00:00